Back to results

Virginia Tech

The use of tetrahydrocannabinol (marinol) in cancer patients undergoing chemotherapy

Abstract

dc:description.abstract

The effect of Marinol, which contains the antiemetic tetrahydrocannabinol (THC), was evaluated in five cancer patients undergoing chemotherapy. Subjects rated their nausea and vomiting, food intake, appetite and mood status three times daily. Drug therapy (THC) or no drug was administered for an average of four months during the course of their chemotherapy regimen. Subjects began taking THC the first day of chemotherapy and continued (5mg/three times a day) for an average of two weeks. Subjects reported their nausea and vomiting to be increased while receiving THC which coincided with their period of chemotherapy treatment. Subjective ratings for food intake and appetite varied in each case and did not always correlate with actual caloric intake from food. Food intake in most subjects was approximately the same, or greater with THC even though the period when THC was given coincided with chemotherapy treatment, and the use of emetigenic drugs. This resulted in weight maintenance or minor weight loss in most subjects. The absence of THC during chemotherapy treatment resulted in decreased food intake. Some of the moods reported most frequently by subjects while receiving THC were activity, interaction, and relaxation. Depression, social withdrawal, and anxiety were reported less frequently and usually occurred around the time of chemotherapy. The majority of the moods reported indicated that subjects had positive feelings associated with THC therapy. The results of this study indicated that THC benefitted cancer patients by increasing food intake during chemotherapy regimens without causing adverse behavioral changes.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Human Nutrition and Foods
Department dc:contributor.department
Human Nutrition and Foods
Grantor dc:publisher
Virginia Tech
Year dc:date.issued
1988

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Sacks, Nancy

Rights

dc:rights
Statement dc:rights
  • In Copyright

Identifiers

dc:identifier.*
Dc Identifier Other
etd-10132010-020253
OAI identifier oai:identifier
oai:vtechworks.lib.vt.edu:10919/45182

Chain of custody

source
Harvested from
Virginia Tech
Base URL
vtechworks.lib.vt.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
related terms
citation

Sacks, Nancy. The use of tetrahydrocannabinol (marinol) in cancer patients undergoing chemotherapy. masters thesis, Virginia Tech, 1988. http://hdl.handle.net/10919/45182